Team:Uppsala/saffron

From 2013.igem.org

(Difference between revisions)
 
(35 intermediate revisions not shown)
Line 1: Line 1:
-
{{Team:Uppsala/standard-style}}
 
{{Team:Uppsala/saffron-style}}
{{Team:Uppsala/saffron-style}}
 +
{{Team:Uppsala/standard-style}}
<html>
<html>
Line 13: Line 13:
</style>
</style>
 +
<script type="text/javascript">
 +
/*Acts once the document is loaded*/ $(document).ready(function() { /*Move the tn-main-wrap as child of <body>*/ $("#tn-main-wrap-wrap").prependTo($("body")); /*Move the menubars in the tn-main-wrap*/ $("#menubar.left-menu").appendTo($("#tn-main-wrap")); $("#menubar.right-menu").appendTo($("#tn-main-wrap"));
 +
/*Spoiler JS*/ $(".tn-spoiler div").slideUp(); $(".tn-spoiler a").click(function(e) { e.preventDefault(); $(".tn-spoiler-active").removeClass("tn-spoiler-active"); $(this).parent().addClass("tn-spoiler-active"); $(".tn-spoiler").not(".tn-spoiler-active").children("div").slideUp(); $(".tn-spoiler-active").children("div").slideToggle(); });
 +
/*Add favicon*/ $("link[rel='shortcut icon']").remove(); $("head").append("<link rel='shortcut icon' type='image/png' href='https://static.igem.org/mediawiki/2013/6/6d/Uppsalas-cow-con.png'>"); });
 +
</script>
 +
 +
<link href="https://2013.igem.org/Team:Uppsala/lightbox-css-code.css?action=raw&ctype=text/css" type="text/css" rel="stylesheet">
 +
 +
<script src="https://2013.igem.org/Team:Uppsala/jquery-code.js?action=raw&ctype=text/javascript" type="text/javascript"></script>
 +
 +
<script src="https://2013.igem.org/Team:Uppsala/lightbox-code.js?action=raw&ctype=text/javascript" type="text/javascript"></script>
</head>
</head>
Line 26: Line 37:
<!-- Contains sub-logo picture -->
<!-- Contains sub-logo picture -->
-
<div id="igem_logo"><a href="https://2013.igem.org/Main_Page"><img class="igem_logo" src="https://static.igem.org/mediawiki/2013/5/59/IGEMlogo.png"></a></div>
+
<div id="igem_logo"><a href="https://2013.igem.org/Team:Uppsala"><img class="igem_logo" src="https://static.igem.org/mediawiki/2013/e/e0/Uppsala2013_IGEMlogo.png"></a></div>
-
<div id="igem"><a href="https://2013.igem.org/Main_Page"><img class="igem" src="https://static.igem.org/mediawiki/2013/9/9c/Uppsala_IGEM_log_blue.png"></a></div>
+
<div id="igem"><a href="https://2013.igem.org/Main_Page"><img class="igem" src="https://static.igem.org/mediawiki/2013/b/b8/Uppsala2013_Uppsala_IGEM_log_blue.png"></a></div>
 +
 
 +
<img class="slogan" src="https://static.igem.org/mediawiki/2013/a/ad/Uppsala2013_Header.png">
</div>  
</div>  
Line 43: Line 56:
<li><a href="https://2013.igem.org/Team:Uppsala/project" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/a/aa/Uppsala2013_Project.png"></a>
<li><a href="https://2013.igem.org/Team:Uppsala/project" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/a/aa/Uppsala2013_Project.png"></a>
<ul>
<ul>
-
<li><a href="https://2013.igem.org/Team:Uppsala/overview">Overview</a></li>
+
<li><a href="https://2013.igem.org/Team:Uppsala/chassi">Chassi</a>
<li><a href="https://2013.igem.org/Team:Uppsala/chassi">Chassi</a>
<ul>
<ul>
Line 56: Line 69:
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a>
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a>
                                                     <ul>
                                                     <ul>
-
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid">P-coumaric acid</a></li>
+
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid">p-Coumaric acid</a></li>
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li>
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li>
Line 62: Line 75:
                                                                 <li><a  
                                                                 <li><a  
href="https://2013.igem.org/Team:Uppsala/saffron">Saffron</a></li>
href="https://2013.igem.org/Team:Uppsala/saffron">Saffron</a></li>
-
<li><a href="https://2013.igem.org/Team:Uppsala/astraxantin">Astaxanthin</a></li>
+
<li><a href="https://2013.igem.org/Team:Uppsala/astaxanthin">Astaxanthin</a></li>
-
<li><a href="https://2013.igem.org/Team:Uppsala/zeaxantin">Zeaxanthin</a></li>
+
<li><a href="https://2013.igem.org/Team:Uppsala/zeaxanthin">Zeaxanthin</a></li>
</ul></li>
</ul></li>
</li>  
</li>  
Line 70: Line 83:
<li><a href="https://2013.igem.org/Team:Uppsala/chromoproteins">Chromoproteins</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/chromoproteins">Chromoproteins</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/safety-experiment">Safety experiment</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/safety-experiment">Safety experiment</a></li>
-
<li><a href="https://2013.igem.org/Team:Uppsala/result">Result</a></li>
+
<li><a href="https://2013.igem.org/Team:Uppsala/results">Results</a></li>
Line 77: Line 90:
<li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a>
<li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a>
<ul>
<ul>
-
<li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway">P-Coumaric acid</a></li>
+
<li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway">Kinetic model</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li>
 +
 +
<li><a href="https://2013.igem.org/Team:Uppsala/toxicity-model">Toxicity model</a></li>
</ul></li>
</ul></li>
<li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li>
Line 87: Line 102:
<li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li>
-
<li><a href="https://2013.igem.org/Team:Uppsala/advisors">Advisors</a></li>
+
                                                <li><a href="https://2013.igem.org/Team:Uppsala/advisors">Advisors</a></li>
 +
</ul></li>
</ul></li>
-
<li><a href="https://2013.igem.org/Team:Uppsala/hp" id="list_type3"><img class="nav-text"      src="https://static.igem.org/mediawiki/2013/b/b8/Uppsala2013_HP.png"></a>
+
<li><a href="https://2013.igem.org/Team:Uppsala/human-practice" id="list_type3"><img class="nav-text"      src="https://static.igem.org/mediawiki/2013/b/b8/Uppsala2013_HP.png"></a>
<ul>
<ul>
-
<li><a href="https://2013.igem.org/Team:Uppsala/Yoghurtproducts">Yoghurt +</a></li>
+
<li><a href="https://2013.igem.org/Team:Uppsala/yoghurt">Yoghurt +</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/synbioday">SynBioDay</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/synbioday">SynBioDay</a></li>
-
<li><a href="https://2013.igem.org/Team:Uppsala/safety">Biosafety and ethics</a></li>
+
<li><a href="https://2013.igem.org/Team:Uppsala/biosafety-and-ethics">Biosafety and ethics</a></li>
-
<li><a href="https://2013.igem.org/Team:Uppsala/society">Society and opinion</a></li>
+
<li><a href="https://2013.igem.org/Team:Uppsala/public-opinion">Public opinion </a></li>
-
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/outreach">Media outreach</a></li>
+
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/Outreach">High school & media </a></li>
-
                                                <li><a href="https://2013.igem.org/Team:Uppsala/highschool-outreach">High school outreach</a></li>
+
<li><a href="https://2013.igem.org/Team:Uppsala/bioart">BioArt</a></li>
 +
<li><a href="https://2013.igem.org/Team:Uppsala/LactonutritiousWorld">A LactoWorld</a></li>
 +
<li><a href="https://2013.igem.org/Team:Uppsala/killswitches">Killswitches</a></li>
 +
<li><a href="https://2013.igem.org/Team:Uppsala/realization">Patent</a></li>
</ul></li>
</ul></li>
-
<li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a>
+
<li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a></li>  
-
                                <ul>
+
-
                                    <li><a href="https://2013.igem.org/Team:Uppsala/collaboration">Collaboration</a></li>
+
-
                                </ul></li>  
+
<li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a>
<li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a>
                                     <ul>
                                     <ul>
                                         <li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li>
                                         <li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li>
 +
                                        <li><a href="https://2013.igem.org/Team:Uppsala/protocols">Protocols</a></li>
                                     </ul></li>
                                     </ul></li>
</ul>
</ul>
-
</div>
+
</div>  
</div>
</div>
Line 113: Line 130:
<div id="main_content"> <!-- Put content here -->
<div id="main_content"> <!-- Put content here -->
-
     <h1 class="main-title">Saffron</h1>
+
     <h1 class="main-title-left">Saffron</h1>
 +
 
 +
    <img class="metabolic-pic" src="https://static.igem.org/mediawiki/2013/5/5f/Uppsala2013_Saffronmini.png">
 +
 
 +
    <div id="clear"></div>
     <h1>Saffron made accessible</h1>
     <h1>Saffron made accessible</h1>
-
     <p>The carotenoid pathway provides an incredible range of metabolites, just waiting to be utilized. Despite this, the availability is today quite limited, at least within the scope of an iGEM project. For our project, we decided to focus on the pathway that leads from <a href="https://2013.igem.org/Team:Uppsala/zeaxantin">zeaxanthin</a> (a derivative of <a href="https://2013.igem.org/Team:Uppsala/betacarotene">beta-Carotene</a>) to the main providers of taste and color in saffron: picrocrocin, crocin and safranal. This is a pathway that had previously been admitted to the registry, but never made available as a part. We decided to characterize each separate gene and further make them available for use.</p>
+
     <p>The carotenoid pathway provides an incredible range of metabolites, just waiting to be utilized. Despite this, the availability is today quite limited, at least within the scope of an iGEM project. For our project, we decided to focus on the pathway that leads from <a href="https://2013.igem.org/Team:Uppsala/zeaxanthin">zeaxanthin</a> (a derivative of <a href="https://2013.igem.org/Team:Uppsala/betacarotene">beta-Carotene</a>) to the main providers of taste and color in saffron: picrocrocin, crocin and safranal<sup><a href="#ref_point">[1]</a></sup>. This is a pathway that had previously been admitted to the registry, but never made available as a part. We decided to characterize each separate gene and further make them available for use.</p>
 +
   
 +
    <div id="pic-box">
 +
<div> 
 +
<a href="https://static.igem.org/mediawiki/2013/9/99/Uppsala2013_saffron1.jpg" data-lightbox="roadtrip" title="Crocus Sativus, the flower from which saffron can be extracted."><img class="pic-1" src="https://static.igem.org/mediawiki/2013/9/99/Uppsala2013_saffron1.jpg"></a>
 +
</div>   
 +
    <a href="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_saffron3.jpg" data-lightbox="roadtrip" tilte="Saffron samples in different dilutions."><img class="pic-2" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_saffron3.jpg"></a>
 +
 
 +
<div id="clear"></div>
 +
<i class="fig-left"><b>Figure 1</b> Crocus Sativus, the flower from which saffron can be extracted.</i>
 +
 
 +
<i class="fig-right"><b>Figure 2</b>  Saffron samples in different dilutions.</i>
 +
 
 +
<div id="clear"></div>
-
    <img>
 
     <h1>The compounds</h1>
     <h1>The compounds</h1>
 +
 +
    </div>
 +
 +
    <div id="clear"></div>
     <p>Picrorocin, crocin and safranal are all derivatives of zeaxanthin. Picrocrocin, along with safranal are the main providers in the characteristic taste of saffron, while crocin is responsible for the color of said spice. Apart from antioxidative properties, shown to have some positive health benefits, these compounds provide an intriguing flavoring and coloring option for a probiotic product.</p>
     <p>Picrorocin, crocin and safranal are all derivatives of zeaxanthin. Picrocrocin, along with safranal are the main providers in the characteristic taste of saffron, while crocin is responsible for the color of said spice. Apart from antioxidative properties, shown to have some positive health benefits, these compounds provide an intriguing flavoring and coloring option for a probiotic product.</p>
-
     <a id="b1"><h1>Methods</h1></a>
+
     <a id="b1"></a><h1>Methods</h1>
 +
 
 +
    <p>The genes for zeaxanthin 7,8-cleavage dioxygenase (ZCD) and Uracil gycosyltransferase (UGTCs2) were obtained in the a synthetic construct provided to us by the Washinton University iGEM-team WashU 2012. The genes were individually isolated with PCR using primers with overhangs containing the ribosome binding site B0034 for expression in E.coli (only for UGTCs2), and 6x-his tag for characterization purposes. Additionally, each part was isolated with only biobrick overhangs for increased modularity in further use. We also designed a primer with an additional restriction site for fusing a synthetic histidine patch thioredoxin to the zeaxanthin 7,8-cleavage dioxygenase to solve solubility issues reported by previous users.
 +
We attempted assembly with strong and weak constitutive promoters from the J23-series for expression in E.coli, as well as our new CP-series for use in both E.coli and lactobacillus. E.coli and lactobacillus on all our constructs.</p>
-
    <p>The genes for zeaxanthin 7,8-cleavage dioxygenase (ZCD) and Uracil gycosyltransferase (UGTCs2) were obtained in the a synthetic construct provided to us by the Washinton University iGEM-team WashU 2012. The genes were individually isolated with PCR using primers with overhangs containing the ribosome binding site B0034 for expression in e.coli (only for UGTCs2), and 6x-his tag for characterization purposes. Additionally, each part was isolated with only biobrick overhangs for increased modularity in further use. We also designed a primer with an additional restriction site for fusing a synthetic histidine patch thioredoxin to the zeaxanthin 7,8-cleavage dioxygenase to solve solubility issues reported by previous users.
+
        <a href="https://static.igem.org/mediawiki/2013/9/9c/Uppsala2013_Saffron_plasmid_and_molecules.png" data-lightbox="roadtrip"><img class="methods-pic" src="https://static.igem.org/mediawiki/2013/9/9c/Uppsala2013_Saffron_plasmid_and_molecules.png"></a>
-
We attempted assembly with strong and weak constitutive promoters from the J23-series for expression in e.coli, as well as our new CP-series for use in both e.coli and lactobacillus. e.coli and lactobacillus on all our constructs.</p>
+
<h1>Results</h1>
<h1>Results</h1>
Line 146: Line 185:
<p>We succeeded in the cloning and sequencing of several biobricks isolated from the synthetic construct we received from WashU 2012. Sequencing was done at GATC biotech and Uppsala Genome center. </p>
<p>We succeeded in the cloning and sequencing of several biobricks isolated from the synthetic construct we received from WashU 2012. Sequencing was done at GATC biotech and Uppsala Genome center. </p>
-
<li>ZCD with only biobrick prefix/suffix  BBa_K1033110</li>
+
<li> <a href="http://parts.igem.org/Part:BBa_K1033110">BBa_K1033110</a> - Zeaxanthin 7,8-cleavage dioxygenase (ZCD) </li>
-
<li>ZCD with 6xHistidine-Patch and biobrick prefix/suffix  BBa_K1033111</li>
+
<li> <a href="http://parts.igem.org/Part:BBa_K1033111">BBa_K1033111</a> - Zeaxanthin 7,8-cleavage dioxygenase (ZCDHis) with His tag </li>
-
<li>UGTCs2 with only biobrick prefix/suffix  BBa_K1033112</li>
+
<li> <a href="http://parts.igem.org/Part:BBa_K1033112">BBa_K1033112</a> - "Uracil glucosyltransferase (UGTCs2)" </li>
-
<li>UGTCs2 with ribosome binding site B0034, 6xHistidine-Patch and biobrick prefix/suffix  BBa_K1033113</li>
+
<li> <a href="http://parts.igem.org/Part:BBa_K1033113">BBa_K1033113</a> - Uracil glucosyltransferase (B0034UGTCs2-6xHis) with RBS and Histag </li>
-
<li>Histidine Thiordeoxin Patch with ribosome binding site B0034 and biobrick prefix/suffix  BBa_K1033115</li>
+
<li> <a href="http://parts.igem.org/Part:BBa_K1033115">BBa_K1033115</a> - Histidine Patch Thioredoxin </li>
 +
<h1>References</h1>
 +
<a>[1]</a> http://www.leffingwell.com/download/saffron.pdf
 +
<br><br>
 +
<a>[2]</a> http://www.tandfonline.com/doi/abs/10.1081/FRI-100100281#.UhUO4tK-2So
 +
<br><br>
 +
<a>[3]</a> http://pubs.acs.org/doi/abs/10.1021/jf062638l
 +
<br><br>
 +
<a>[4]</a> http://www.sciencedirect.com/science/article/pii/S0944711310003028
 +
<br><br>
 +
<a>[5]</a> http://online.liebertpub.com/doi/abs/10.1089/dna.2007.0631?journalCode=dna
 +
<br><br> Figure 1 is taken from wikimedia commons
Line 158: Line 208:
<div id="bottom-pic">
<div id="bottom-pic">
-
<img class="bottom-pic" src="https://static.igem.org/mediawiki/2013/a/aa/Bottom_picture.png">
+
</div>
</div>

Latest revision as of 15:28, 28 October 2013

Saffron

Saffron made accessible

The carotenoid pathway provides an incredible range of metabolites, just waiting to be utilized. Despite this, the availability is today quite limited, at least within the scope of an iGEM project. For our project, we decided to focus on the pathway that leads from zeaxanthin (a derivative of beta-Carotene) to the main providers of taste and color in saffron: picrocrocin, crocin and safranal[1]. This is a pathway that had previously been admitted to the registry, but never made available as a part. We decided to characterize each separate gene and further make them available for use.

Figure 1 Crocus Sativus, the flower from which saffron can be extracted. Figure 2 Saffron samples in different dilutions.

The compounds

Picrorocin, crocin and safranal are all derivatives of zeaxanthin. Picrocrocin, along with safranal are the main providers in the characteristic taste of saffron, while crocin is responsible for the color of said spice. Apart from antioxidative properties, shown to have some positive health benefits, these compounds provide an intriguing flavoring and coloring option for a probiotic product.

Methods

The genes for zeaxanthin 7,8-cleavage dioxygenase (ZCD) and Uracil gycosyltransferase (UGTCs2) were obtained in the a synthetic construct provided to us by the Washinton University iGEM-team WashU 2012. The genes were individually isolated with PCR using primers with overhangs containing the ribosome binding site B0034 for expression in E.coli (only for UGTCs2), and 6x-his tag for characterization purposes. Additionally, each part was isolated with only biobrick overhangs for increased modularity in further use. We also designed a primer with an additional restriction site for fusing a synthetic histidine patch thioredoxin to the zeaxanthin 7,8-cleavage dioxygenase to solve solubility issues reported by previous users. We attempted assembly with strong and weak constitutive promoters from the J23-series for expression in E.coli, as well as our new CP-series for use in both E.coli and lactobacillus. E.coli and lactobacillus on all our constructs.

Results

Summary

We managed to clone both UGTCs2 and ZCD with and without RBS and His-tag, as well as subcloning the synthetic histidine patch thioredoxin, and verified the result by sequencing. We experienced issues assembling our constructs with promoters, as well as the histidine patch thioredoxin with ZCD. We managed to mutagenize a UGTCs2 construct with a promoter, and characterization was attempted using western blot with a negative result.

Characterization

From previous user experiences, we know that zeaxanthin 7,8-cleavage dioxygenase in its native form forms inclusion bodies in the cytoplasm of probiotic cells. These insoluble inclusion bodies form aggregates, which inhibits growth of the transformed bacteria. We decided to solve this problem by fusing the enzyme with a synthetic histidine patch thioredoxin domain that increases solubility of the translated product. This was done by including a NgoMIV restriction site found right at the end of the thioredoxin sequence in the overhang of forward cloning primer of the ZCD gene, and use this to ligate the two. While all clonings of ZCD were successful, neither the ligation of ZCD and histidine patch thioredoxin, nor the assembly of promoters to the histidine patch thioredoxin were successful.

All clonings of UGTCs2 were successful. We did not manage to assemble any promoters to the gene by means of biobrick asssembly, but we did manage to perform a mutagenesis with primers containing a J23-series promoter. This construct was analyzed with a western blot experiment that showed a negative result. We can only speculate on this lack of expression. Previous experiences do not mention any difficulties expressing Uracil gycosyltransferase, but the descriptions on this area are generally quite lacking.

Biobricks

We succeeded in the cloning and sequencing of several biobricks isolated from the synthetic construct we received from WashU 2012. Sequencing was done at GATC biotech and Uppsala Genome center.

  • BBa_K1033110 - Zeaxanthin 7,8-cleavage dioxygenase (ZCD)
  • BBa_K1033111 - Zeaxanthin 7,8-cleavage dioxygenase (ZCDHis) with His tag
  • BBa_K1033112 - "Uracil glucosyltransferase (UGTCs2)"
  • BBa_K1033113 - Uracil glucosyltransferase (B0034UGTCs2-6xHis) with RBS and Histag
  • BBa_K1033115 - Histidine Patch Thioredoxin
  • References

    [1] http://www.leffingwell.com/download/saffron.pdf

    [2] http://www.tandfonline.com/doi/abs/10.1081/FRI-100100281#.UhUO4tK-2So

    [3] http://pubs.acs.org/doi/abs/10.1021/jf062638l

    [4] http://www.sciencedirect.com/science/article/pii/S0944711310003028

    [5] http://online.liebertpub.com/doi/abs/10.1089/dna.2007.0631?journalCode=dna

    Figure 1 is taken from wikimedia commons